Pharmaceutical executive with a blend of successful experience in large, mid-size and startups in North America and Asia, with national and global responsibility for various business functions including General Management, Sales & Marketing, Market Access & Business Development.
Launched two companies in US and have led product launches as well as life cycle management of major brands in both primary care and specialty space. Served as member of Executive committee and have a successful track record of developing agile and inventive business cultures capable of achieving ambitious, “big-pharma” scale marketing initiatives on thrifty budgets.
His most recent success as a Chief Commercial Officer was the US launch of Diclegis for Duchesnay, one of the top-performing new product launches of 2013, achieved through a highly effective market access initiative and ground-breaking digital strategies. His professional history reflects the ability to drive paradigm change using cost-effective and scalable strategies that fully leverage marketing resources, including virtual organization structure, KOL network activation, and skilled application of customer research.
Previously, Sanjiv served as SVP WW Commercial & Country Head for US for NicOx, a French-based pharmaceutical platform technology company, and before that, oversaw strategic marketing for Biovail. The prior 15 years were spent with Sanofi-Aventis, where Sanjiv rose from sales rep in Canada to become the Director Global Marketing, New Products Commercialization, Metabolism & Cardiovascular. There, he successfully drove global marketing strategy for Sanofi Aventis’ GLP-1 and its diabetes portfolio.
Sanjiv received BSc (Hons) from Delhi University in India and his MBA with Distinction, from the Richard Ivey School of Business at the University of Western Ontario, Canada.
Mohan Purushothaman is a thought leader in the Pharmaceutical Pricing, Reimbursement and Market Access space. He has several years of experience in the Pharma industry followed by more than a decade of work as a strategic advisor to various pharmaceutical companies. After spending 5 years at Roche where he headed the pricing and contracting group, he built a successful practice at Net Margins and went on to lead a global practice at Alliance Life Sciences. In these challenging assignments, he guided the development of strategies for a number of products across multiple therapeutic areas and markets.
He has been an active entrepreneur and responsible for giving shape to multiple business concepts at the core of new business ventures over the last decade. As a co-founder and President of Progentec Diagnostics, he is actively involved in exploring and commercializing new technologies in the diagnostic and therapeutic areas.
He holds a Ph.D. from the Johns Hopkins University with a focus on Pharmaceutical Pricing. Prior to that, he was a Research Fellow at Harvard University.